A Multi-Center, Randomized, Double-Blind, Placebo-controlled Study of Adalimumab in Japanese Subjects with Moderately to Severely Active Ulcerative Colitis - Trial 2014-004559-29
Access comprehensive clinical trial information for 2014-004559-29 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie Inc. and is currently status unknown. The study focuses on Ulcerative Colitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-004559-29
Trial Details
EU Clinical Trials Register • 2014-004559-29
A Multi-Center, Randomized, Double-Blind, Placebo-controlled Study of Adalimumab in Japanese Subjects with Moderately to Severely Active Ulcerative Colitis
Study Focus
Sponsor & Location
AbbVie Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
•History of subtotal colectomy with ileorectostomy or colectomy with ileoanal pouch, Koch pouch, or ileostomy for ulcerative colitis or was planning bowel surgery.
ICD-10 Classifications
Ulcerative colitis
Other ulcerative colitis
Ulcerative colitis, unspecified
Arthropathy in ulcerative colitis
Juvenile arthritis in ulcerative colitis
Data Source
EU Clinical Trials Register
2014-004559-29
Non-Device Trial